NCT06858189 Promoting Active Therapy: Path to Wellness
| NCT ID | NCT06858189 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Kansas State University |
| Condition | Depression, Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 60 participants in total. It began in 2025-02-28 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will examine changes in depression and anxiety following a 10-week intervention promoting nature-based physical activity in mental health settings. We will recruit ten licensed therapists whose caseload includes adults with depression and anxiety. Following a training by our team, each participating therapist will recruit six clients, who will be randomly assigned to the intervention or control condition. Clients in the intervention condition will engage in walk-and-talk therapy outdoors during weekly sessions and discuss strategies for being active outdoors on their own. We will assess changes in depression, anxiety, and nature-based physical activity in both groups.
Eligibility Criteria
Inclusion Criteria: * Current client of a participating therapist who has completed study training * Diagnosed depressive or anxiety disorder * Able to safely engage in moderate physical activity * Willing to complete all study requirements Exclusion Criteria: * Planning to discontinue therapy in less than 6 months * Active suicidal ideation * Does not pass exercise risk screener
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06858189 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Depression, Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06858189 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06858189 currently recruiting?
Yes, NCT06858189 is actively recruiting participants. Contact the research team at emailey@ksu.edu for enrollment information.
Where is the NCT06858189 trial being conducted?
This trial is being conducted at Manhattan, United States.
Who is sponsoring the NCT06858189 clinical trial?
NCT06858189 is sponsored by Kansas State University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.